APV Workshop: Drug-Device Combination Products for Parenteral Use

June 9–10, 2026 | Novartis Campus | Basel, Switzerland

We are delighted to share that nuvalore will participate in the upcoming APV Workshop: Drug-Device Combination Products for Parenteral Use,
organized by the APV – International Association for Pharmaceutical Technology.

This workshop brings together experts across pharmaceutical development, drug delivery, analytical sciences, device engineering, and regulatory affairs to discuss current challenges and innovations in drug-device combination products for parenteral therapies. Key focus areas include:

• Autoinjectors, prefilled syringes, and wearable injection devices
• High-concentration biologics and digitally connected delivery systems
• Regulatory expectations, usability considerations, and sustainability in device engineering

We are especially proud that Dr. Anamarija Ćurić, Founder and Managing Director of nuvalore, is serving on the workshop programme committee and contributing to the scientific program development.

As biologics and patient-centric delivery systems continue to evolve, robust analytical characterization and GMP-aligned quality control are becoming increasingly important throughout development and commercialization. nuvalore supports this evolution by providing GMP-certified analytical services, including stability studies, method development and validation, and force measurement testing tailored for injectable systems, primary packaging, and combination products.

Will you be attending the workshop in Basel? We welcome the opportunity to connect and discuss how our analytical strategies can support your drug-device development programs.